Literature DB >> 19439368

CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Xiuyan Huang1, Ashley D Reynolds, R Lee Mosley, Howard E Gendelman.   

Abstract

CD4+ T cells orchestrate innate and adaptive immunity. In the central nervous system they modulate immune responses including cell trafficking and glial neuroregulatory functions through an array of soluble molecules cell-cell interactions affecting tissue homeostasis. During disease their roles evolve to an auto-aggressive or, alternatively, protective phenotype. How such a balance is struck in the setting of neurodegenerative disorders may reflect a dichotomy between regulatory T cell, anti-inflammatory and neuroprotective activities versus effector T cell inflammation and neurodegeneration. Interestingly, such roles may show commonalities amongst neurodegenerative diseases. Herein we focus on strategies to modulate such CD4+ T cell responses for therapeutic gain.

Entities:  

Mesh:

Year:  2009        PMID: 19439368      PMCID: PMC2696588          DOI: 10.1016/j.jneuroim.2009.04.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  228 in total

Review 1.  The mononuclear phagocyte system revisited.

Authors:  David A Hume; Ian L Ross; S Roy Himes; R Tedjo Sasmono; Christine A Wells; Timothy Ravasi
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

Review 2.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  [Parkinson's disease: cell death mechanisms]

Authors:  P.-P. Michel; E.-C. Hirsch; Y. Agid
Journal:  Rev Neurol (Paris)       Date:  2002       Impact factor: 2.607

Review 4.  Helping the CD8(+) T-cell response.

Authors:  Michael J Bevan
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

5.  The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function.

Authors:  Jeppe Falsig; Peter Pörzgen; Søren Lund; André Schrattenholz; Marcel Leist
Journal:  J Neurochem       Date:  2006-01-09       Impact factor: 5.372

Review 6.  Innate recognition of viruses.

Authors:  Andreas Pichlmair; Caetano Reis e Sousa
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

Review 7.  Significance of the parkin gene and protein in understanding Parkinson's disease.

Authors:  Paul S Fishman; George A Oyler
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

8.  Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.

Authors:  Amanda J Chase; Hung-Chih Yang; Hao Zhang; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation.

Authors:  Florence Pinto; Talma Brenner; Phyllis Dan; Miron Krimsky; Saul Yedgar
Journal:  Glia       Date:  2003-12       Impact factor: 7.452

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  26 in total

1.  Peripheral leukocyte populations and oxidative stress biomarkers in aged dogs showing impaired cognitive abilities.

Authors:  Paolo Mongillo; Daniela Bertotto; Elisa Pitteri; Annalisa Stefani; Lieta Marinelli; Gianfranco Gabai
Journal:  Age (Dordr)       Date:  2015-04-24

Review 2.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

3.  Regulatory T cells in CNS injury: the simple, the complex and the confused.

Authors:  James T Walsh; Jonathan Kipnis
Journal:  Trends Mol Med       Date:  2011-07-07       Impact factor: 11.951

Review 4.  Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

Authors:  Katherine E Olson; Aditya N Bade; Charles R Schutt; Jingdong Dong; Scott J Shandler; Michael D Boska; R Lee Mosley; Howard E Gendelman; Yutong Liu
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

6.  Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two.

Authors:  Elisa Bisicchia; Valerio Chiurchiù; Maria Teresa Viscomi; Laura Latini; Filomena Fezza; Luca Battistini; Mauro Maccarrone; Marco Molinari
Journal:  Cell Mol Life Sci       Date:  2013-01-08       Impact factor: 9.261

7.  Progenitor cells: therapeutic targets after traumatic brain injury.

Authors:  Robert A Hetz; Supinder S Bedi; Scott Olson; Alex Olsen; Charles S Cox
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

8.  Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease.

Authors:  André Charlett; R John Dobbs; Sylvia M Dobbs; Clive Weller; Mohammad A A Ibrahim; Tracy Dew; Roy Sherwood; Norman L Oxlade; J Malcolm Plant; James Bowthorpe; Andrew J Lawson; Alan Curry; Dale W Peterson; Ingvar T Bjarnason
Journal:  Gut Pathog       Date:  2009-11-26       Impact factor: 4.181

Review 9.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

Review 10.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.